{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:36:51Z","timestamp":1777329411501,"version":"3.51.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s10354-010-0788-z","type":"journal-article","created":{"date-parts":[[2010,7,17]],"date-time":"2010-07-17T10:40:22Z","timestamp":1279363222000},"page":"286-292","source":"Crossref","is-referenced-by-count":14,"title":["Polypharmazie und Schmerztherapie","Polypharmacy and pain treatment"],"prefix":"10.1007","volume":"160","author":[{"given":"Markus","family":"Gosch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"B\u00f6hmdorfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Benvenuti-Falger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Dovjak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Iglseder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Lechleitner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Otto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina E.","family":"Roller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Sommeregger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,1]]},"reference":[{"key":"788_CR1","first-page":"317","volume":"18","author":"HD Basler","year":"2004","unstructured":"Basler HD, Hesselbarth S, Schuler M. Schmerzdiagnostik und -therapie in der Geriatrie. Teil 1. Schmerzdiagnostik. Schmerz, 18: 317\u2013326, 2004","journal-title":"Schmerzdiagnostik. Schmerz"},{"key":"788_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2165\/00002512-200320010-00003","volume":"20","author":"MP Davies","year":"2003","unstructured":"Davies MP, Srivastava M. Demographics, assessment and management of pain in the elderly. Drugs Aging, 20: 23\u201357, 2003","journal-title":"Drugs Aging"},{"issue":"Suppl","key":"788_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/AJP.0b013e31802be869","volume":"23","author":"T Hadjistavropoulos","year":"2007","unstructured":"Hadjistavropoulos T, Herr K, Turk DC, et al. An interdisciplinary expert consensus statement on assessment of pain in older persons. Clin J Pain, 23(Suppl): S1\u2013S43, 2007","journal-title":"Clin J Pain"},{"key":"788_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1532-5415.1997.tb04501.x","volume":"45","author":"GP Stoehr","year":"1997","unstructured":"Stoehr GP, Ganguli M, Seaberg EC, et al. Over-the-counter medication use in an older rural community: the MoVIES Project. J Am Geriatr Soc, 45: 158\u2013165, 1997","journal-title":"J Am Geriatr Soc"},{"key":"788_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1055\/s-2007-959300","volume":"132","author":"D Rottlaender","year":"2007","unstructured":"Rottlaender D, Scherner M, Schneider T, et al. Multimedikation, Compliance und Zusatzmedikation bei Patienten mit kardiovaskul\u00e4ren Erkrankungen. Dtsch Med Wochenschr, 132: 139\u2013144, 2007","journal-title":"Dtsch Med Wochenschr"},{"key":"788_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/fampra\/cml067","volume":"24","author":"U Junius Walker","year":"2007","unstructured":"Junius Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract, 24: 14\u201319, 2007","journal-title":"Fam Pract"},{"key":"788_CR7","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.amjopharm.2006.12.005","volume":"4","author":"P Sawyer","year":"2006","unstructured":"Sawyer P, Bodner EV, Ritchie CS, et al. Pain and pain medication use in community-dwelling older adults. Am J Geriatr Pharmacother, 4: 316\u2013324, 2006","journal-title":"Am J Geriatr Pharmacother"},{"key":"788_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","volume":"329","author":"M Pirmohamed","year":"2004","unstructured":"Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ, 329: 15, 2004","journal-title":"BMJ"},{"key":"788_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2125.2006.02831.x","volume":"63","author":"M Laroche","year":"1997","unstructured":"Laroche M, Charmes J, Nouaille Y, et al. Is inappropriate medication use a major cause of adverse drug reactions in the elderly. Br J Clin Pharmacol, 63: 177\u2013186, 1997","journal-title":"Br J Clin Pharmacol"},{"key":"788_CR10","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1001\/archinte.165.20.2414","volume":"165","author":"DH Solomon","year":"2005","unstructured":"Solomon DH, Avorn J, Katz JN, et al. Compliance with osteoporosis medications. Arch Intern Med, 165: 2414\u20132419, 2005","journal-title":"Arch Intern Med"},{"key":"788_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00508-008-1089-z","volume":"120","author":"J Schuler","year":"2008","unstructured":"Schuler J, D\u00fcckelmann C, Beindl W, et al. Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria. Wien Klin Wochenschr, 120: 733\u2013741, 2008","journal-title":"Wien Klin Wochenschr"},{"key":"788_CR12","first-page":"284","volume":"6","author":"HP Wirth","year":"2006","unstructured":"Wirth HP, H\u00fcrlimann R, Fl\u00fcckiger T. NSAR und Cox-2-Hemmer: die h\u00e4ufigsten unerw\u00fcnschten Wirkungen. Schweiz Med Forum, 6: 284\u2013289, 2006","journal-title":"Schweiz Med Forum"},{"key":"788_CR13","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1046\/j.1532-5415.2002.50607.x","volume":"50","author":"G Onder","year":"2002","unstructured":"Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). JAGS, 50: 1962\u20131968, 2002","journal-title":"JAGS"},{"key":"788_CR14","unstructured":"ATC-DDD system (online), available from URL: http:\/\/www.whocc.no\/atcddd\/atsystem.html#6 (assessed 18 February 2008)"},{"issue":"Suppl 7","key":"788_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/ndt\/13.suppl_7.25","volume":"13","author":"A Baraldi","year":"1998","unstructured":"Baraldi A, Ballestri M, Rapana R, et al. Acute renal failure of medical type in an elderly population. Nephrol Dial Transplant, 13(Suppl 7): 25\u201329, 1998","journal-title":"Nephrol Dial Transplant"},{"key":"788_CR16","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/pds.1641","volume":"17","author":"HL Smets","year":"2008","unstructured":"Smets HL, De Haes JF, De Swaef A, et al. Exposure of the elderly to potential nephrotoxic drug combinations in Belgium. Pharmacoepidemiol Drug Saf, 17: 1014\u20131019, 2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"788_CR17","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1001\/archinte.160.6.777","volume":"160","author":"J Page","year":"2000","unstructured":"Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underecognized public health problem. Arch Intern Med, 160: 777\u2013784, 2000","journal-title":"Arch Intern Med"},{"key":"788_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2165\/00002018-199717050-00001","volume":"17","author":"AG Johnson","year":"1997","unstructured":"Johnson AG. NSAIDs and increased blood pressure. What is clinical significance? Drug Saf, 17: 277\u2013289, 1997","journal-title":"Drug Saf"},{"key":"788_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.7326\/0003-4819-121-4-199408150-00011","volume":"121","author":"AG Johnson","year":"1994","unstructured":"Johnson AG, Nguyan TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med, 121: 289\u2013300, 1994","journal-title":"Ann Intern Med"},{"key":"788_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2165\/00003495-199651020-00001","volume":"51","author":"PW de Leeuw","year":"1996","unstructured":"de Leeuw PW. Nonsteriodal anti-inflammatory drugs and hypertension. The risk in perspective. Drugs, 51: 179\u2013187, 1996","journal-title":"Drugs"},{"key":"788_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0140-6736(03)12509-3","volume":"361","author":"TM MacDonald","year":"2003","unstructured":"MacDonald TM, Wie L. Effect of ibuprufen on cardioprotective effect of aspirin. Lancet, 361: 573\u2013574, 2003","journal-title":"Lancet"},{"key":"788_CR22","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1161\/01.CIR.0000132491.96623.04","volume":"109","author":"L Garcia-Rodriguez","year":"2004","unstructured":"Garcia-Rodriguez L, Varas-Lorenzo C, Maguire A, et al. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population. Circulation, 109: 3000\u20133006, 2004","journal-title":"Circulation"},{"key":"788_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1503\/cmaj.070186","volume":"177","author":"JA Delaney","year":"2007","unstructured":"Delaney JA, Opatrny L, Brophy JM, et al. Drug\u2013drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ, 177: 347\u2013351, 2007","journal-title":"CMAJ"},{"key":"788_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0033-3182(96)71592-X","volume":"37","author":"BP Skop","year":"1996","unstructured":"Skop BP, Brown TM. Potential bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics, 37: 12\u201316, 1996","journal-title":"Psychosomatics"},{"key":"788_CR25","first-page":"1","volume-title":"The Peripheral Actions of 5-hydroxyltryptamine","author":"TJ Verbeuren","year":"1989","unstructured":"Verbeuren TJ. Synthesis, storage, release and metabolism of 5-hydroxyltryptamine in peripheral tissues. In: Fozard JR (ed) The Peripheral Actions of 5-hydroxyltryptamine. New York, NY: Oxford University Press, pp 1\u201325, 1989"},{"issue":"Suppl 3","key":"788_CR26","first-page":"40","volume":"8","author":"F De Clerck","year":"1990","unstructured":"De Clerck F. The role of serotonin in thrombogenesis. Clin Physiol Biochem, 8(Suppl 3): 40\u201349, 1990","journal-title":"Clin Physiol Biochem"},{"key":"788_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2036.2007.03541.x","volume":"27","author":"YK Loke","year":"2008","unstructured":"Loke YK, Trivel AN, Ingh S. Meta-analysis: gastrointestinal bleeding due to interaction between selektive serotonin reuptake inhibitors and non steroidal inflammatory drugs. Aliment Pharmacol Ther, 27: 31\u201340, 2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl D","key":"788_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/jac\/26.suppl_D.7","volume":"26","author":"R Janknegt","year":"1990","unstructured":"Janknegt R. Drug interactions with quinolones. J Antimicrob Chemoter, 26(Suppl D): 7\u201329, 1990","journal-title":"J Antimicrob Chemoter"},{"issue":"4","key":"788_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2165\/00044011-200929040-00006","volume":"29","author":"Z Iqbal","year":"2009","unstructured":"Iqbal Z, Khan A, Naz A, et al. Pharmacokinetic interaction of ciprofloxacin with diclofenac: a single dose, two-period crossover study in healthy adult volunteers. Clin Drug Investig, 29: 4, 275\u2013281, 2009","journal-title":"Clin Drug Investig"},{"key":"788_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2165\/00002018-199513060-00004","volume":"13","author":"P Ball","year":"1996","unstructured":"Ball P, Tillotson G. Tolerability of flouroquinolone antibiotics: past, present and future, Drug Saf, 13: 343, 1996","journal-title":"Drug Saf"},{"key":"788_CR31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.7326\/0003-4819-134-4-200102200-00027","volume":"134","author":"H Sone","year":"2001","unstructured":"Sone H, Takahashi A, Yamada N. Ibuprofen-related hypoglycaemia in a patient receiving sulfonylurea. Ann Intern Med, 134: 344, 2001","journal-title":"Ann Intern Med"},{"key":"788_CR32","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1046\/j.1365-2125.1999.00996.x","volume":"48","author":"M Collin","year":"1999","unstructured":"Collin M, Mucklow JC. Drug interactions, renal impairment and hypoglycaemia in a patient with Type II diabetes. Br J Clin Pharmacol, 48: 134\u2013137, 1999","journal-title":"Br J Clin Pharmacol"},{"key":"788_CR33","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/00000542-200504000-00019","volume":"102","author":"RS Sinatra","year":"2005","unstructured":"Sinatra RS, Jahr JS, Reynolds LW, et al. Efficacy and safety of single and repeated administration of 1 gram intravenous acetominophen injection (paracetamol) for pain management after major orthopedic surgery. Anesthesiology, 102: 822\u2013832, 2005","journal-title":"Anesthesiology"},{"key":"788_CR34","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s001080050083","volume":"38","author":"CH Gleiter","year":"1997","unstructured":"Gleiter CH. Paracetamol \u2013 das sichere Analgetikum. Internist, 38: 707\u2013712, 1997","journal-title":"Internist"},{"key":"788_CR35","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1096\/fj.07-8506com","volume":"22","author":"B Hinz","year":"2008","unstructured":"Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selektive cyclooxygenase-2 inhibitor in man. FASEB J, 22: 383\u2013390, 2008","journal-title":"FASEB J"},{"key":"788_CR36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1742-7843.2006.pto_248.x","volume":"98","author":"A Gonzalez-Perez","year":"2006","unstructured":"Gonzalez-Perez A, Garcia Rodriguez L. Upper gastrointestinal complications among users of paracetamol. Basic Clin Pharmacol Toxicol, 98: 297\u2013303, 2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"788_CR37","first-page":"1621","volume":"91","author":"I Mahe","year":"2006","unstructured":"Mahe I, Bertrand N, Drouet L, et al. Interaction between paracetamol and warfarin in patients: a double-blind, pacebo-controlled, randomized study. Haematologica, 91: 1621\u20131627, 2006","journal-title":"Haematologica"},{"key":"788_CR38","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/01.HYP.0000177437.07240.70","volume":"46","author":"JP Forman","year":"2005","unstructured":"Forman JP, Stampfer MJ, Curhan GC. Non-narcotic analgesic dose and risk of incident hypertension in US women. Hypertension, 46: 500\u2013507, 2005","journal-title":"Hypertension"},{"key":"788_CR39","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1161\/CIRCULATIONAHA.105.595793","volume":"113","author":"AT Chan","year":"2006","unstructured":"Chan AT, Manson JE, Albert CM, et al. Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation, 113: 1578\u20131587, 2006","journal-title":"Circulation"},{"key":"788_CR40","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/hep.20948","volume":"42","author":"A Larsen","year":"2005","unstructured":"Larsen A, Poison J, Fontana R, et al. Acetaminophen-induced acute liver failure: results of a US Multicenter, prospective study. Hepatology, 42: 1364\u20131372, 2005","journal-title":"Hepatology"},{"key":"788_CR41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2125.1979.tb00922.x","volume":"7","author":"E Perucca","year":"1979","unstructured":"Perucca E, Richens A. Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs. Br J Clin Pharmacol, 7: 201\u2013206, 1979","journal-title":"Br J Clin Pharmacol"},{"key":"788_CR42","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/00045391-200501000-00009","volume":"12","author":"MJ Toes","year":"2005","unstructured":"Toes MJ, Jones AL, Prescott L. Drug interactions with paracetamol. Am J Ther, 12: 56\u201366, 2005","journal-title":"Am J Ther"},{"key":"788_CR43","unstructured":"Reinhardt N, Jantos R, Sinning C, et al. Renaissance eines Analgetikums. Pharmazeutische Zeitschrift, 32, 2006 (online)"},{"key":"788_CR44","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0014-2999(99)00477-X","volume":"378","author":"C Campos","year":"1999","unstructured":"Campos C, de Gregorio R, Garcia-Nieto R, et al. Regulation of cyclooxygenase activity by metamizol. Eur J Pharmacol, 378: 339\u2013347, 1999","journal-title":"Eur J Pharmacol"},{"key":"788_CR45","first-page":"420","volume-title":"Arzneimittelneben- und -wechselwirkungen","author":"EJ Verspohl","year":"2001","unstructured":"Verspohl EJ. Analgetika mit antipyretischer und antiphlogistischer Wirkungskomponente. In: Ammon HPT (Hrsg) Arzneimittelneben- und -wechselwirkungen. 4. Auflage, WVG: Stuttgart, pp 420\u2013424, 2001","edition":"4"},{"key":"788_CR46","unstructured":"Fachinformation Novalgin\u00ae, August 2004. Aventis Pharma"},{"key":"788_CR47","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jama.1986.03380230037008","volume":"256","author":"M Levy","year":"1986","unstructured":"Levy M. Risks of agranulocytosis and aplastic anaemia: the international agranulocytosis and aplastic anaemia study. J Am Med Assoc, 256: 1749\u20131757, 1986","journal-title":"J Am Med Assoc"},{"key":"788_CR48","unstructured":"Arzneimittelkommission der dt. \u00c4rzteschaft, Arzneiverordnungen. 21. Auflage, pp 214\u2013216, 2006"},{"key":"788_CR49","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/sj.clpt.6100138","volume":"83","author":"T Saussele","year":"2007","unstructured":"Saussele T, Burk O, Blievernicht JK, et al. Selective induction of human hepatic cytochromes P450 2B6 and 3A4 by metamizole. Clin Pharmacol Ther, 83: 265\u2013274, 2007","journal-title":"Clin Pharmacol Ther"},{"key":"788_CR50","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1213\/01.ane.0000189613.61910.32","volume":"102","author":"Th Enggaard","year":"2006","unstructured":"Enggaard Th, Poulsen L, Arendt-Nielsen L, et al. The analgesic effect of tramadol after intravenous injection in healthy volunteers in relation to CYP2D6. Anesth Analg, 102: 146\u2013150, 2006","journal-title":"Anesth Analg"},{"issue":"Suppl 2","key":"788_CR51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2165\/00003495-199700532-00006","volume":"53","author":"P Dayer","year":"1997","unstructured":"Dayer P, Desmeules J, Collart L. Pharmacology of tramadol. Drugs, 53(Suppl 2): 18\u201324, 1997","journal-title":"Drugs"},{"key":"788_CR52","unstructured":"Opioids+benzodiazepines, stockleys drug interactions, medicines complete. In: Baxter K (ed) London, UK: RPS Publishing, http:\/\/www.medicinescomplete.com\/mc , 01\/08\/2008"},{"key":"788_CR53","unstructured":"Serotonin reuptake inhibitors\/tramadol. In: Tatro DS (ed) Drug Interaction Facts, Facts and Comparisons 4.0. St. Louis, MI, USA: Wolters Kluwer Health Inc., http:\/\/online.factsandcomparisons.com , 14\/05\/2009"},{"key":"788_CR54","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/014107689909200915","volume":"92","author":"S Kesavan","year":"1999","unstructured":"Kesavan S, Sobala GM. Serotonin syndrome with fluoxetine plus tramadol. J R Soc Med, 92: 474\u2013475, 1999","journal-title":"J R Soc Med"},{"key":"788_CR55","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5694\/j.1326-5377.2005.tb06825.x","volume":"182","author":"IW Boyd","year":"2005","unstructured":"Boyd IW. Tramadol and seizures. Med J Aust, 182: 595\u2013596, 2005","journal-title":"Med J Aust"},{"key":"788_CR56","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2165\/00002018-200225020-00004","volume":"25","author":"F Pisani","year":"2002","unstructured":"Pisani F, Oteri G, Costa C, et al. Effects of psychotropic drugs on seizure threshold. Drug Saf, 25: 91\u2013110, 2002","journal-title":"Drug Saf"},{"issue":"Suppl A","key":"788_CR57","first-page":"15","volume":"4","author":"JA Desmeules","year":"2000","unstructured":"Desmeules JA. The tramadol option. Eur J Pain, 4(Suppl A): 15\u201321, 2000","journal-title":"Eur J Pain"},{"key":"788_CR58","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1358\/dot.2003.39.7.799445","volume":"39","author":"D Hedges","year":"2003","unstructured":"Hedges D, Jeppson K, Whitehead P. Antipsychotic medication and seizures: a review. Drugs Today, 39: 551\u2013557, 2003","journal-title":"Drugs Today"},{"key":"788_CR59","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/sj.bjp.0703562","volume":"131","author":"H Potschka","year":"2000","unstructured":"Potschka H, Friderichs E, Loscher W. Anticonvulsant and proconvulsant effects of tramadol, its enantiomers and its M1 metabolite in the rat kindling model of epilepsy. Br J Pharmacol, 131: 203\u2013212, 2000","journal-title":"Br J Pharmacol"},{"key":"788_CR60","unstructured":"Tramadol Hydrochloride, American Hospital Formulary Service Drug Information, Medicines Complete. In: McEvoy GK (ed) London, UK: RPS Publishing, http:\/\/www.medicinescomplete.com\/mc , 07\/07\/2008"},{"key":"788_CR61","unstructured":"Opioids+Antiepileptics; Enzyme-inducing, Stockleys Drug Interactions, Medicines Complete. In: Baxter K (ed) London, UK: RPS Publishing, http:\/\/www.medicinescomplete.com\/mc , 15\/12\/2008"},{"key":"788_CR62","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1213\/00000539-200206000-00033","volume":"94","author":"R Arcioni","year":"2002","unstructured":"Arcioni R, della Rocca M, Roman\u00f2 S, et al. Ondansetron inhibits the analgesic effects of tramadol: a possible 5-HT(3) spinal receptor involvement in acute pain in humans. Anesth Analg, 94: 1553\u20131557, 2002","journal-title":"Anesth Analg"},{"key":"788_CR63","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1097\/00000539-200105000-00045","volume":"92","author":"JL De Witte","year":"2001","unstructured":"De Witte JL, Schoenmaekers B, Sessler DI, et al. The analgesic efficacy of tramadol is impaired by concurrent administration of ondansetron. Anesth Analg, 92: 1319\u20131321, 2001","journal-title":"Anesth Analg"},{"key":"788_CR64","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00228-004-0783-7","volume":"60","author":"K Hedenmalm","year":"2004","unstructured":"Hedenmalm K, Lindh JD, Sawe J, et al. Increased liability of tramadol-warfarin interaction in individuals with mutations in the cytochrome P450 2D6 gene. Eur J Clin Pharmacol, 60: 369\u2013372, 2004","journal-title":"Eur J Clin Pharmacol"},{"key":"788_CR65","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/j.1875-9114.1998.tb03914.x","volume":"18","author":"JR Sabbe","year":"1998","unstructured":"Sabbe JR, Sims PJ, Sims MH. Tramadol-warfarin interaction. Pharmacotherapy, 18: 871\u2013873, 1998","journal-title":"Pharmacotherapy"},{"key":"788_CR66","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00228-005-0947-0","volume":"61","author":"F Penning-van Beest","year":"2005","unstructured":"Penning-van Beest F, Erkens J, Petersen KU, et al. Main comedications associated with major bleeding during anticoagulant therapy with coumarins. Eur J Clin Pharmacol, 61: 439\u2013444, 2005","journal-title":"Eur J Clin Pharmacol"},{"key":"788_CR67","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/BF03016672","volume":"55","author":"ST Rang","year":"2008","unstructured":"Rang ST, Field J, Irving C. Serotonin toxicity caused by an interaction between fentanyl and paroxetine. Can J Anaesth, 55: 521\u2013525, 2008","journal-title":"Can J Anaesth"},{"key":"788_CR68","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2710.2007.00813.x","volume":"32","author":"S Ailawadhi","year":"2007","unstructured":"Ailawadhi S, Sung KW, Carlson LA, et al. Serotonin syndrome caused by interaction between citalopram and fentanyl. J Clin Pharm Ther, 32: 199\u2013202, 2007","journal-title":"J Clin Pharm Ther"},{"key":"788_CR69","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/gerona\/61.2.165","volume":"61","author":"A Won","year":"2006","unstructured":"Won A, Lapane KL, Vallow S, et al. Long-term effects of analgesics in a population of elderly nursing home residents with peristent nonmalignant pain. J Gerontol A Biol Sci Med Sci, 61: 165\u2013169, 2006","journal-title":"J Gerontol A Biol Sci Med Sci"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-010-0788-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-010-0788-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-010-0788-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-010-0788-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T13:21:00Z","timestamp":1711632060000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-010-0788-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":69,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["788"],"URL":"https:\/\/doi.org\/10.1007\/s10354-010-0788-z","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}